150 related articles for article (PubMed ID: 24145197)
41. Tumor suppressor p53: regulation and function.
Somasundaram K
Front Biosci; 2000 Apr; 5():D424-37. PubMed ID: 10762600
[TBL] [Abstract][Full Text] [Related]
42. The molecular perspective: p53 tumor suppressor.
Goodsell DS
Oncologist; 1999; 4(2):138-9. PubMed ID: 10337384
[No Abstract] [Full Text] [Related]
43. mTOR favors senescence over quiescence in p53-arrested cells.
Schug TT
Aging (Albany NY); 2010 Jun; 2(6):327-8. PubMed ID: 20603524
[No Abstract] [Full Text] [Related]
44. GSIV serine/threonine kinase can induce apoptotic cell death via p53 and pro-apoptotic gene Bax upregulation in fish cells.
Reshi L; Wu HC; Wu JL; Wang HV; Hong JR
Apoptosis; 2016 Apr; 21(4):443-58. PubMed ID: 26833308
[TBL] [Abstract][Full Text] [Related]
45. Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.
Young RM; Ackerman D; Quinn ZL; Mancuso A; Gruber M; Liu L; Giannoukos DN; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
Genes Dev; 2013 May; 27(10):1115-31. PubMed ID: 23699409
[TBL] [Abstract][Full Text] [Related]
46. p53-mediated activation of the mitochondrial protease HtrA2/Omi prevents cell invasion.
Yamauchi S; Hou YY; Guo AK; Hirata H; Nakajima W; Yip AK; Yu CH; Harada I; Chiam KH; Sawada Y; Tanaka N; Kawauchi K
J Cell Biol; 2014 Mar; 204(7):1191-207. PubMed ID: 24662565
[TBL] [Abstract][Full Text] [Related]
47. Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D.
Krześniak M; Zajkowicz A; Matuszczyk I; Rusin M
Mech Ageing Dev; 2014 Jul; 139():11-21. PubMed ID: 24915467
[TBL] [Abstract][Full Text] [Related]
48. mTORC1 and p53: clash of the gods?
Hasty P; Sharp ZD; Curiel TJ; Campisi J
Cell Cycle; 2013 Jan; 12(1):20-5. PubMed ID: 23255104
[TBL] [Abstract][Full Text] [Related]
49. p53 and senescence: a little goes a long way.
Long JS; Ryan KM
Cell Cycle; 2010 Oct; 9(20):4050-1. PubMed ID: 21058422
[No Abstract] [Full Text] [Related]
50. Selling long life.
Scott CT; DeFrancesco L
Nat Biotechnol; 2015 Jan; 33(1):31-40. PubMed ID: 25574633
[No Abstract] [Full Text] [Related]
51. The interfaces between signal transduction pathways: IGF-1/mTor, p53 and the Parkinson Disease pathway.
Levine AJ; Harris CR; Puzio-Kuter AM
Oncotarget; 2012 Nov; 3(11):1301-7. PubMed ID: 23211569
[No Abstract] [Full Text] [Related]
52. Wild-type p53 inhibits protein kinase CK2 activity.
Schuster N; Götz C; Faust M; Schneider E; Prowald A; Jungbluth A; Montenarh M
J Cell Biochem; 2001; 81(1):172-83. PubMed ID: 11180407
[TBL] [Abstract][Full Text] [Related]
53. Parkinson's disease: don't mess with calcium.
Mattson MP
J Clin Invest; 2012 Apr; 122(4):1195-8. PubMed ID: 22446181
[TBL] [Abstract][Full Text] [Related]
54. The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.
Armata HL; Garlick DS; Sluss HK
Cancer Res; 2007 Dec; 67(24):11696-703. PubMed ID: 18089799
[TBL] [Abstract][Full Text] [Related]
55. Regulation of the aging process by autophagy.
Salminen A; Kaarniranta K
Trends Mol Med; 2009 May; 15(5):217-24. PubMed ID: 19380253
[TBL] [Abstract][Full Text] [Related]
56. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation.
Ye P; Liu Y; Chen C; Tang F; Wu Q; Wang X; Liu CG; Liu X; Liu R; Liu Y; Zheng P
Mol Cell; 2015 Feb; 57(4):708-720. PubMed ID: 25639470
[TBL] [Abstract][Full Text] [Related]
57. Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways.
Chen Z; Yi W; Morita Y; Wang H; Cong Y; Liu JP; Xiao Z; Rudolph KL; Cheng T; Ju Z
Nat Commun; 2015 Apr; 6():6808. PubMed ID: 25879755
[TBL] [Abstract][Full Text] [Related]
58. C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling.
Chen MB; Jiang Q; Liu YY; Zhang Y; He BS; Wei MX; Lu JW; Ji Y; Lu PH
Carcinogenesis; 2015 Sep; 36(9):1061-70. PubMed ID: 26116623
[TBL] [Abstract][Full Text] [Related]
59. Senescence regulation by mTOR.
Dulic V
Methods Mol Biol; 2013; 965():15-35. PubMed ID: 23296649
[TBL] [Abstract][Full Text] [Related]
60. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation.
Minella AC; Swanger J; Bryant E; Welcker M; Hwang H; Clurman BE
Curr Biol; 2002 Oct; 12(21):1817-27. PubMed ID: 12419181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
